Glaxo Launches Flonase OTC, Banks On More Consumer Growth Drivers
This article was originally published in The Tan Sheet
Executive Summary
CEO Andrew Witty says the consumer business GSK is forming through brand divestitures and its JV with Novartis is a part of “the company I've been trying to create for seven years.” GSK’s OTC Flonase reached U.S. stores Feb. 3, a sign of additional product launches he expects the consumer health JV to do.